Berodual N (ipratropium bromide/fenoterol hydrobromide)
/ Boehringer Ingelheim
- LARVOL DELTA
Home
Next
Prev
1 to 6
Of
6
Go to page
1
February 20, 2024
Pulmonary Strongyloidiasis and Hyperinfection in a High-Risk Factors Patient
(ATS 2024)
- "Case presentation: A 70 year-old famer man diagnosed with COPD from 2015 and having stable treatment with Seretide 25/250 mcg : 2 canisters x 2/day,Berodual when acute breatheless without any exacerbations in two previous years. March 2022 the patient was diagnosed with lymphoma non-hogkin and commencing with chemotherapy every 3 weeks including:Rituximab 1400mg,Cyclophosphamid 500 mg, Epirubicin hydroclorid 50 mg, Vincristin sulfat 2 mg, Methylprednisolon 40 mg...Chest CTscan: diffuse glass -ground opacities in both lungs and the cavitary lesion in upper right lung S5Patient's Progress:Patient was started on treatment Meropenem 1g,Tygacil 50 mg, Ivermectin 6 mg plus Albendazole 400 mg and his immunosuppressants were stopped...Cyclophosphamidec...However, diagnosis might be challenging due to non-specific clinical features. Thus, a high level of suspicion is mandatory for early diagnosis,especially in immunocompromised patients."
Clinical • Anorexia • Chronic Obstructive Pulmonary Disease • Hematological Malignancies • Immunology • Infectious Disease • Lymphoma • Non-Hodgkin’s Lymphoma • Oncology • Pain • Pulmonary Disease • Respiratory Diseases • Septic Shock
March 04, 2024
Continuous Versus Intermittent Nebulization Therapy in Acute Asthma Exacerbation at Emergency Department
(clinicaltrials.gov)
- P=N/A | N=40 | Not yet recruiting | Sponsor: Thammasat University
New trial • Asthma • Immunology • Pulmonary Disease • Respiratory Diseases
July 14, 2022
The AOTMiT Council will prepare positions on drugs in lung cancer and cystic fibrosis
(Puls Medycyny)
- "The next meeting of the AOTMiT Transparency Council, scheduled for Monday (July 18), will be devoted to, inter alia, preparing positions on drugs used in the treatment of lung cancer and cystic fibrosis....Preparation of a position on the legitimacy of granting the reimbursement consent for Rezurock (belumosudil) in the indication: treatment of adult and pediatric patients 12 years of age and older with chronic graft versus host disease (chronic GVHD) after failure of at least two previous lines of systemic treatment....Fenoteroli hydrobromidum + ipratropii bromidum in the indications: cystic fibrosis...Ipratropii bromidum in the indications: cystic fibrosis..."
Reimbursement • Chronic Graft versus Host Disease • Graft versus Host Disease
June 29, 2022
"@FcoFdzClamont @salud_comision @SaludEdomex Gracias por surtir medicamentos. Aunque no dan tratamiento en @INSABI_mx @Juanferrer62 para asma/EPOC, al menos hay hoy me dieron un sustituto (Berodual) del Combivent @boehringerus ."
(@laliz41)
May 06, 2022
A randomized clinical trial on inhaled ciclesonide for managing acute asthma in the emergency room.
(PubMed, Sao Paulo Med J)
- "Inhaled ciclesonide was not inferior to systemic hydrocortisone for managing acute asthma exacerbations, and it improved both clinical and spirometric parameters."
Clinical • Journal • Asthma • Immunology • Pulmonary Disease • Respiratory Diseases
April 14, 2022
"Ich frag jetzt einfach mal so frech, Hilft Berodual Dosieraerosol bei Covid Husten lieber Herr @florian_krammer ?"
(@OmarBad24358384)
Novel Coronavirus Disease
1 to 6
Of
6
Go to page
1